Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Glenmark Pharmaceuticals Limited
Press Release Apr 11 2022
Business
Apr 11 2022
4 min read

Press Release Apr 11 2022

Glenmark Pharmaceuticals Limited has informed the Exchange about press release dated 11-Apr-2022 titled Glenmark Specialty S.A. receives approval for conducting Phase 1 Clinical Trial of its Novel Molecule GRC 54276 in patients with Advanced Solid Tumors and Hodgkin���s Lymphoma

View Attachment